 |
|
Antihemophilic Factor VIII in HemophiliaUse of Concentrates to Permit Major Surgery
Joseph J. Mazza, MD;
E. J. Walter Bowie, BM, BCh;
Albert B. Hagedorn, MD;
Paul Didisheim, MD;
Howard F. Taswell, MD;
Lowell F. A. Peterson, MD;
Charles A. Owen, Jr., MD
JAMA. 1970;211(11):1818-1823.
Abstract
Seven surgical procedures were successfully performed on five patients suffering from classic hemophilia. Hemostasis was maintained by the use of three factor VIII concentrates: cryoprecipitate, American National Red Cross high-purity concentrate, and a lyophilized glycine-precipitated fraction. Significant hemorrhage occurred twice, in each instance when the patient's factor VIII levels fell below 20% of normal. The availability of satisfactory concentrates of factor VIII permits consideration of elective surgical procedures in the hemophiliac. It should be emphasized, however, that such operations should be undertaken only if the indications are unequivocal and the necessary clinical and laboratory facilities are available.
Author Affiliations
From the sections of internal medicine (hematology), clinical pathology, and orthopedic surgery, Mayo Clinic and Mayo Foundation, and the Mayo Graduate School of Medicine (University of Minnesota), Rochester.
Footnotes
Reprint requests to Mayo Clinic, Rochester, Minn 55901.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Prostatectomy in an 85-Year-Old Hemophiliac
Wylin and Schneider
Arch Surg 1976;111:818-821.
ABSTRACT
Elective Ocular Surgery in Hemophilia
Richards and Spurling
Arch Ophthalmol 1973;89:167-168.
ABSTRACT
Hydrocephalus in Child With von Willebrand's Disease: Treatment by Ventriculoperitoneal Shunt
Cooper et al.
Arch Pediatr Adolesc Med 1971;121:340-343.
ABSTRACT
The Use of Factor VIII and Factor IX Concentrates During Surgery
George and Breckenridge
JAMA 1970;214:1673-1676.
ABSTRACT
|
